Candela Medical, Inc., a leading name in the medical device industry, is headquartered in the United States and operates extensively across North America and Europe. Founded in 1970, the company has established itself as a pioneer in aesthetic and surgical laser technologies, focusing on innovative solutions for dermatology and plastic surgery. Candela's core offerings include advanced laser systems for hair removal, skin rejuvenation, and vascular treatments, distinguished by their efficacy and safety. The company is renowned for its commitment to research and development, which has led to numerous industry accolades and a strong market position. With a legacy of excellence and a dedication to enhancing patient outcomes, Candela Medical continues to shape the future of aesthetic medicine.
How does Candela Medical, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Candela Medical, Inc.'s score of 23 is lower than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Candela Medical, Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. As a current subsidiary, Candela Medical, Inc. may inherit climate-related data and commitments from its parent organisation; however, no specific details or figures have been provided regarding such cascaded information. The lack of emissions data and reduction initiatives suggests that the company may still be in the early stages of developing its climate strategy or reporting framework. In the context of the medical technology industry, it is increasingly important for companies to establish clear climate commitments and reduction targets to align with global sustainability goals.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Candela Medical, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

